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Abstract
Background—We systematically reviewed the genetic variants associated with stroke in 
genome-wide association studies (GWAS) and examined the emerging priorities and opportunities 
for rapidly advancing stroke research in the era of Trans-Omics science.
Methods—Using the PRISMA guideline, we searched PubMed and NHGRI- EBI GWAS catalog 
for stroke studies from 2007 till May 2017.
Results—We included 31 studies. The major challenge is that the few validated variants could 
not account for the full genetic risk of stroke and have not been translated for clinical use. None of 
the studies included continental Africans. Genomic study of stroke among Africans presents a 
unique opportunity for the discovery, validation, functional annotation, trans-omics study and 
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translation of genomic determinants of stroke with implications for global populations. This is 
because all humans originated from Africa, a continent with a unique genomic architecture and a 
distinctive epidemiology of stroke; as well as substantially higher heritability and resolution of 
fine mapping of stroke genes.
Conclusion—Understanding the genomic determinants of stroke and the corresponding 
molecular mechanisms will revolutionize the development of a new set of precise biomarkers for 
stroke prediction, diagnosis and prognostic estimates as well as personalized interventions for 
reducing the global burden of stroke.
Keywords
Stroke; Stroke Epidemiology; Genetic Research; Trans-omics; African Ancestry Population; 
GWAS; SNP; Genomics
1.0 INTRODUCTION
Stroke is a leading cause of long-term disability, depression and dementia globally.1, 2 For 
over 15 years, stroke remains the second most common cause of death worldwide with a 
higher burden among people of African ancestry compared to other populations.2–5 The 
lifetime risk of stroke has been estimated as one in five for middle-aged women and one in 
six for middle-aged men.6 Developing precise interventions to prevent and mitigate the 
devastating consequences of stroke requires a clear understanding of the environmental and 
genomic risk factors as well as the unique molecular pathways influencing its occurrence, 
type and outcome.2
We systematically reviewed the literature on genetic variants associated with stroke in 
genome-wide association studies (GWAS) and examined the emerging priorities and 
opportunities for rapidly advancing stroke research in the era of Trans-Omics science by 
including African ancestry populations, especially those from the continent of Africa.
2.0 METHODS
2.1 Search Strategy
Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guideline, we searched the National Human Genome Research Institute-European 
Bioinformatics Institute GWAS catalog up till May 7, 2017. In addition, we searched 
PubMed for relevant stroke GWAS studies from 2007 till May 7, 2017. Search terms 
included “GWAS” “stroke”, “ischemic stroke”, “hemorrhagic stroke”, “lacunar 
stroke”/”small vessel stroke”, and “large artery atherosclerosis”, and “cardioembolic 
stroke”/”cardiogenic stroke”.
2.2 Eligibility Criteria
We included individual GWAS studies and consortia studies with meta-analysis of GWAS 
focusing on stroke or stroke subtypes. We excluded Matsushita et al (2010)7 and Zhang et al 
(2012)8 which were large candidate gene studies, Zhang et al (2014)9 which was a whole 
exome sequencing (WES) study, Cole et al (2012)10 and Zhou et al ( 2014) 11 which were 
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small WES studies examining 10 and 9 subjects respectively; Opherk et al (2014) 12 which 
described white mater hyperintensity (WMH) volume in cerebral autosomal-dominant 
arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL); Keene et al 
(2014)13 which described SNPs significantly associated with Vitamins B6 and B12 in stroke 
patients (not as a risk of stroke); and Traylor et al (2017)14 which was not a GWAS study, 
but an heritability study which also applied genetic risk score.
3.0 RESULTS
We included 31 studies (Figure 1) presented in Tables 1 and 2. Five studies were individual 
GWAS while 26 were meta-analyses. We provided information on year of publication, 
phenotype, sample size, sample ancestry, genetic loci, single nucleotide polymorphisms 
(SNPs), associated traits, odds ratio and p-values as well as replication status.
Based on this systematic review, only 24 genetic loci have been found to be associated with 
stroke. Many of them have neither been validated nor fine-mapped. Up to 61% have small to 
moderate effect sizes with odds ratios < 1.5. About 87% of the study subjects were European 
Caucasian, while only 10% were African Americans; however none was from the African 
continent.”
4.0 DISCUSSION
4.1 Genomic variants associated with stroke
Stroke is a heterogenous trait which includes brain infarction (ischemic stroke with blockage 
of blood flow); spontaneous intracerebral hemorrhage (bleeding in the brain) or 
subarachnoid haemorrhage.15 It is defined based on pathological, imaging, or other objective 
evidence of vascular brain injury in a defined vascular distribution; or clinical evidence of 
focal vascular brain injury based on symptoms persisting beyond 24 hours or until death, 
with other etiologies excluded.15 The pathway to the occurrence of stroke involves the 
cardiovascular cascade including cardiovascular risk factors (e.g. hypertension, diabetes, 
dyslipidemia, obesity16), and intermediate phenotypes such as atherosclerosis and 
microaneurysms.2, 17 This makes unravelling the precise genomic determinants of its 
occurrence, type, severity and outcome and the delineation of its underlying mechanisms 
challenging.
Nevertheless, several genetic loci [PITX2, HDAC9, ZFHX3, 12q24.2 near ALDH2, 1p13.2 
near TSPAN2, CDKN2A/CDKN2B, and others in Tables 1 and 2] have been associated with 
ischemic stroke or its sub-types from genome-wide association studies (GWAS).5, 18–23 
Although some of these loci have been associated with specific subtypes, genetic overlaps 
have also been reported among them.20, 22 For example, large artery atherosclerosis and 
small vessel disease, which were previously treated as genetically distinct, may share a 
substantial genetic component. Thus, combined analyses of both subtypes may increase 
power to identify small-effect alleles influencing shared pathophysiological processes.20, 22 
Furthermore, the novel locus 15q21.3 [AQP9-LIPC gene region] was associated with both 
ischemic and hemorrhagic stroke in African Americans.24
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Genetic variation plays a substantial role in intracerebral hemorrhage (ICH) risk, hematoma 
volume and outcome,.25 Promising candidates for risk alleles in ICH identified in 
populations (which had no continental Africans), include variants of the genes 
Apolipoprotein E (APOE), ACE, PMF1/SLC25A44, COL4A2, and MTHFR 18, 23, 26. Other 
genetic variants related to hemostasis, lipid metabolism, inflammation, and the central 
nervous system microenvironment as well as the locus 1q22 25 have also been linked to ICH 
in single candidate gene studies.26
However, previously reported risk variants, many of which are yet to be validated or fine-
mapped, account for only a portion of inherited genetic influence on ischemic stroke or ICH 
pathophysiology, pointing to additional loci yet to be identified. 2728
4.2 Evidence Gaps
Although evidence for genetic contributions to stroke exist, the scientific community lacks 
the evidence required to translate the current knowledge to clinical and community settings 
for stroke prevention and interventions to improve the health of individuals and populations 
at risk. Translating current findings into causal variants and target genes, is a major 
challenge along this pathway. Additional validation and fine-mapping to improve functional 
annotation for variants, especially those in non-coding regions of the genome, is a necessary 
step to address this challenge.29 This would require a global effort to expand stroke research 
to include more diverse populations, particularly African ancestry population, to elucidate 
the genetics of stroke.
Furthermore, expanding the genetic study of stroke in African populations, a population that 
has significantly higher susceptibility to stroke, will help elucidate the global heritability of 
stroke; as well as assist in developing new, and broadening existing, potential therapeutic 
options. This is because novel variants (SNPs/copy number variants CNVs/insertion-
deletions InDels) that contribute to the higher burden, earlier age of onset and poorer 
outcomes of stroke in people of African ancestry are yet to be characterized. 2, 5, 18
4.3 Advantages of conducting stroke genomics research in African populations
Significant advantages exist to conduct stroke research in African ancestry populations. 
Below we outline the reasons for conducting said research:
4.3.1. Universal implications—All modern humans originated in Africa before 
migrating to populate the rest of the world in the last 100,000 years, hence the expression 
‘we are all Africans beneath our skin’. 30–35 Therefore combining phenotype and genomic 
information from continental Africans (old genes in same environment) and the African 
Diaspora (interactions of old genes with modern environments) could lend novel insights 
into human evolution and adaptation, health disparities research, disease etiology, 
pathophysiology, and ancestry-based disease gene mapping. This could have significant 
universal implications for global populations.30–35
4.3.2. Unique genomic architecture—Genetic adaptations that took place across 
Africa, particularly against fatal pathogens and ecological forces, have resulted in elevated 
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frequencies of alleles conferring survival advantages detectable in present-day continental 
Africans and those in the Diaspora.5, 32, 33 Unfortunately, some of these alleles are 
maladaptive contributing to the disproportionately high burden of some chronic diseases in 
these groups.5, 32, 33 The power to detect pathogenic genomic variants associated with such 
alleles is therefore substantially higher among people of African ancestry.
One important example is the 2 missense haplotype variants G1 and G2 in the 
apolipoprotein L1 (APOL1) gene, which have been found to be associated with end-stage 
renal disease in people of African ancestry.5, 18, 32, 33, 36 These haplotypes are common in 
African ancestry populations but absent in European Caucasians and Asians, presumably 
due to evolutionary positive selection because these APOL1 variants confer resistance to 
lethal Trypanosoma brucei infections, which cause African sleeping sickness.5, 18, 32, 33 
Only by studying people of African ancestry, were the associations of the G1 and G2 
APOL1 variants identified, and these variants turned out to account for the large amount of 
the ethnic disparity in end-stage renal disease that had long been recognized between 
African and European ancestry populations.5, 18, 32, 33
Novel insights into disease etiology have also been gained by comparing diasporan 
populations to their ancestral populations in sub-Saharan Africa and by characterizing local 
admixture at disease risk loci.33 A study found that the association between the LPL SNP 
rs328 and lipid levels was stronger and the levels of HDL-cholesterol were higher among 
African Americans with predominantly European ancestry than among those with 
predominantly African ancestry at this locus. 33 Lipid levels and their association with the 
LPL variant in African Americans with two African ancestry alleles at this locus were 
similar to those of West Africans despite widely different lifestyles and diets. 33 This 
mutation possibly occurred centuries ago and was then transported to America through the 
trans-Atlantic slave trade. 33
4.3.3. Greater understanding of stroke epidemiology—Substantial disparities in 
stroke epidemiology exist between people of African ancestry compared to other 
populations. The burden of stroke in Africa is higher and increasing, with stroke being 
among the leading causes of morbidity and mortality throughout continental Africa while 
the burden is less and appears to be declining in many high-income countries.2 Globally, 
Africa has the highest burden of stroke with age standardized incidence of up to 
316/100,000 37; age-adjusted prevalence of as high as1,460/100,000; 38, 39 one month 
fatality of up to 43% 40, (compared to 4% North America)2, 16, 41, and 3 year fatality of 
84% 42. Furthermore, stroke afflicts the younger population (up to 15 years younger2, 43), 
and presents with a higher proportion of the hemorrhagic type (34% in Africans, vs 9 % in 
high income countries). 41 Similarly, African Americans experience a higher burden, more 
hemorrhagic type, younger age of onset and worse outcome compared to European 
Americans. 2, 5
Some of the racial disparity and higher burden of stroke in people of African ancestry can be 
attributed to lifestyle and cardio-metabolic factors (eg diabetes mellitus, and 
hypertension 2, 44) as well as socioeconomic factors such as inadequate access to health 
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care. 5 However, even after adjustment for these factors, substantial risk remains, suggesting 
a strong genetic influence.5, 32, 33, 45, 46
Studying the genetics of stroke in African ancestry populations may elucidate genetic 
mechanisms that could not be otherwise revealed in studies of non-African populations (e.g. 
European ancestry populations). However, most large stroke genomic consortia are based on 
subjects of predominantly European ancestry. As of May 7, 2017, the National Human 
Genome Research Institute-European Bioinformatics Institute GWAS catalog included 12 
GWAS of stroke; in aggregate, these included 40,801 European Caucasian subjects but only 
4,566 African American subjects. No subjects in these studies were from Africa despite the 
higher heritability of stroke in Africans.5, 14
4.3.4. Substantially higher heritability and greater potential for discovery of 
novel genes—It has been demonstrated that there is higher stroke genetic heritability 
among UK African ancestry sample (h2 = 0.35 [SE = 0.19], p = 0.043) compared to 
European populations (h2=0.16). 14 Thus the sample size requirement for detecting 
significant SNPs/CNVs/InDels associations may not be as large as what is often required 
among European populations. Therefore the potential and statistical power for discovery and 
functional investigation of genomic variants associated with stroke appears to be best among 
people of African ancestry.
4.3.5. Substantially better resolution for fine mapping—African ancestry 
populations have been shown to substantially increase the resolution of fine-mapping 5, 47 
due to its low linkage disequilibrium and high genetic heterogeneity.18, 19, 35 This is the 
reason African ancestry data is critically needed (in independent and trans-ethnic analyses) 
to fine-map loci previously identified in GWAS studies of European populations so as to 
pinpoint specific causal variant(s) and gene(s) for various complex diseases including 
stroke. 5, 47
Genomic data for unravelling causative variants can take the form of dense-GWAS29 or 
whole exome sequencing (WES) or whole genome sequencing (WGS). Dense-GWAS using 
novel chips such as the 2.5 million SNPs array H3Africa chip48, 49 with 850K custom 
African content combined with imputation based on 5,500 WGS reference genomes can 
facilitate functional association analysis. 50 (The reference genomes comprise the Genome 
Diversity in Africa Project (GDAP)51, Uganda 2000 Genomes52, African Genome Variation 
Project53, 1000 Genomes54, 55, TrypanoGEN, 48, 49 Baylor College48, 49, and South African 
Human Genome Programme SAHGP48, 49, 56) The advantage of GWAS is that it is cost-
efficient and can cover common variations of small to moderate effects (minor allelic 
frequency MAF>1 %) in large populations. Performing GWAS in people of African ancestry 
will substantially increase the diversity within the GWAS catalogue.50
Whole genome sequencing (WGS) has several advantages over GWAS. WGS covers the 
entire genome and can detect rare variants (with MAF<1 %), as well as other types of 
functionally important variations (copy number variations, insertions/deletions). 57, 58 
Importantly, WGS gives single base resolution of the entire genome which is ~100–300-fold 
finer resolution than that provided by GWAS chips. Also, WGS is not biased by, or restricted 
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to, the SNPs that have been placed on commercially available SNP chips (assumes 
commonly used chip-based methods).57, 58 It provides the best possible resource for linkage 
disequilibrium (LD) mapping due to the maximal marker density and lack of ascertainment 
bias.
Nevertheless WGS is at least 10 times more expensive than GWAS, and produces massive 
amounts of data for analysis (100 to 300 fold more than GWAS data), some of which are of 
uncertain significance.59 With future costs to generate WGS data reducing, WGS in large 
populations of continental Africans with stroke for discovery39; followed by validation in 
African Americans, is the most plausible approach to discover and pinpoint causal variants 
for stroke with implications for the entire human race. This is due to the African origin of all 
humans and the substantially higher heritability of stroke among African ancestry 
populations. Meanwhile, dense GWAS with novel chips and imputation using WGS data can 
also produce useful results, while samples can be stored for future WGS as prices reduce.
4.4 Understanding Complex traits in the era of Trans-Omics science
Although GWAS approach is a very powerful tool to tag genetic loci related to stroke 
etiology, it may not pinpoint the exact causal genetic variation or delineate the mechanistic 
path from DNA variation to regulation of gene transcription, translation and post-translation 
modification, all the way to the pathogenesis of stroke. It is necessary to combine the 
emerging tools of genomics (including genome wide genotyping with novel high throughput 
chips, and next generation whole exome sequencing and whole genome sequencing) with 
functional omics including transcriptomics, epigenomics, proteomics, and metabolomics in 
various integrative manners. Functional omics can further GWAS findings in two ways. 
First, functional omics can offer insight into which and how the static DNA variation leads 
to dynamic functional changes at RNA and protein level. One common application of Trans-
Omics approach is to annotate the expression and methylation quantitative trait loci (eQTL 
and mQTL) for fine-mapping GWAS causal signals. For example, schizophrenia risk-
associated SNPs in the Disrupted In Schizophrenia 1 (DISC1) gene has been shown to 
regulate RNA splicing and thus lead to expression changes of certain isoforms of DISC1 
transcripts60. Prostate cancer risk allele rs11986220 found by GWAS locates in an enhancer 
region and can result in stronger FoxA1 binding and stronger androgen responsiveness.61 
Second, functional omics reflect the results of both endogenous DNA genetic coding and 
exogenous dynamic environmental factors. Thus, it provides a unique opportunity to 
quantify complex gene-gene and gene-environment interactions for complex diseases, to 
which both genetics and environmental factors contribute substantially. Only through Trans-
Omics approach can we draw a complete picture of the biological mechanisms of stroke and 
its various subtypes as well as its outcome. For example a recent publication conducted a 
GWAS of blood pressure in continental Africans and African Americans to identify genes 
conferring susceptibility to increased blood pressure. This research identified three novel 
genomic regions associated with blood pressure and utilized transomic techniques to unravel 
the associated pathways, which have not been previously reported in studies of other race/
ethnicity. 62 Likewise, stroke research utilizing Africans and African ancestry populations 
can produce significant dividends because of the association between high blood pressure 
and stroke in African ancestry populations. 62
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Trans-Omics approach has been utilized successfully in immunology,63, 64 oncology 63, 65 
cardiovascular diseases66, and some neurological diseases such as Alzheimer’s diseases67, 
schizophrenia68 and autism.69 Although still rudimentary, this approach is also being 
employed in stroke research too, mostly using transcriptome and more recently epigenomics. 
For instance, transcriptome study observed that genes regulated in large-vessel 
atherosclerotic stroke are expressed in platelets and monocytes and modulate hemostasis 
while genes regulated in cardioembolic stroke are expressed in neutrophils and modulate 
immune responses to infectious-like stimuli.70 In the development of intracranial aneurysms, 
genomic DNA methylation has been found to play an important role in the genetic 
expression regulation involved in immune and inflammatory reactions, cell function, cell 
maintenance, and cell signal transduction.71 In ischemic stroke patients, CDKN2B 
methylation in peripheral blood leukocytes was found to be associated with carotid artery 
calcification. 72. Epigenomic study discovered that DNA methylation level for TRAF3 gene 
is associated with vascular recurrence in ischemic stroke patients treated with clopidogrel. 73
4.5 Methodological Standards, Current Research Priorities and Opportunities in Stroke 
Genomics and Trans-Omics
Important methodological considerations for stroke genomic research include adequate 
sample size, the selection of appropriate controls, careful clinical phenotyping using 
standardized classification systems, and determining associations with stroke subtypes as 
well as stroke as a whole. It is essential that positive associations are replicated in 
independent (but similar) populations,24 and appropriate methodology is used in such 
studies.74 Top priorities identified for global stroke genomic research include greater sample 
size and research within subtypes of stroke to aid discoveries, translation of existing 
findings, and utilization of novel techniques.75 African ancestry populations are critically 
needed for discovery of novel loci associated with stroke and fine-mapping of known loci 
discovered in American and other populations to pinpoint the precise causal variant(s) and 
gene(s) and translate to clinical applications.5, 47 The largest population of (continental) 
Africans with stroke in a single funded study are included in the Stroke Investigative 
Research and Education Network (SIREN) study76, part of the H3Africa Project, 31, 32, 49 
which has >3000 case-control pairs, (with a targeted recruitment of 5000 case-control pairs) 
accurately phenotyped with the pictographic questionnaire for verification of stroke-free 
status (pQVSFS)77, 78, and ACCESS tool (for standardized phenotyping of ischemic and 
hemorrhagic strokes) 79, 80. Cases and controls are comprehensively evaluated for stroke risk 
factors to ensure appropriate co-variate adjustment. Furthermore, the controls, who are 
recruited from the same catchment population that produced the cases are matched for age, 
sex and ethnicity to minimize confounding due to population structure.2, 5, 44, 76–79. 
Preliminary data (n=917) from candidate gene studies (24 SNPs) in SIREN show that the 
IL-6 rs1800796 was significantly associated with ischemic stroke in West African men (OR 
= 2.006, 95% CI = [1.065, 3.777]. In addition, rs2383207 in CDKN2A/CDKN2B was also 
associated with ischemic stroke in men (OR = 2.550, 95% CI = [1.027, 6.331].81–83 
However, these findings need to be explored further in the entire SIREN dataset.
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To advance stroke genomics with existing opportunities and resources, the following steps 
are most likely to yield the best outcome.
4.6.1 Discovery of novel variants in the continental African dataset—Increasing 
the sample size of the SIREN study with additional 2000 case-control pairs will make it the 
largest ever stroke genomic dataset from a single study (10,000 subjects, 5000 case-control 
pairs). This will give over 81% power to detect Genetic Relative Risk of at least 1.46 with 
minimum allele frequency of 0.05. Thus, the statistical power, the genomic diversity and 
unique allelic frequencies of certain variants in Africans5 as well as substantially higher 
heritability14 will maximize the opportunity for discovery of novel variants (SNPs/CNVs/
InDels) for total stroke, and its predominant subtypes, severity and outcome of relevance to 
African Americans ( 71% of whom migrated from West Africa several centuries ago) and 
indeed the entire human species. 32, 33, 35 Moreover, certain variants may be unique to 
populations of African Ancestry thus accounting for some of the observed racial disparities 
in stroke. The power for discovery will be further enhanced with pathway-based analyses.
4.6.2 Validation and Fine-mapping—Because African subjects are best suited for 
validation and fine-mapping, 5, 47 the phenotype and genomic dataset of 5000 case-control 
pairs (WGS or dense GWAS data with imputation ) should also be utilized for validation; 
and fine-mapping of variants previously associated with stroke in GWAS studies of 
Europeans and other populations. 29, 47, 84, 85 Secondly, variants discovered in continental 
Africans can be validated among African Americans within the Consortium of Minority 
Population Genome-Wide Association Studies of Stroke (COMPASS)24, International 
Stroke Genetics Consortium (ISGC) and other consortia.
4.6.3 Trans-ancestry big data meta-analyses including large datasets from 
people of African ancestry—The data generated in 4.6.1 and 4.6.2 above can be utilized 
in trans-ancestry meta-analysis and fine-mapping within harmonized consortia including 
NINDS-funded Stroke Genetics Network (SiGN)86, METASTROKE, 75 ISGC 75 and 
SIREN-Reasons for Geographic and Racial Differences in Stroke (REGARDS) 
collaboration44 to discover, validate and fine-map additional novel variants associated with 
stroke across European, African and other ancestry populations. This could provide more 
statistical power for discovery, fine-mapping and validation of loci with novel causal 
variant(s) and gene(s) for stroke and stroke types especially when they include large-scale 
African ancestry data.29, 87 It is crucial to promote opportunities for generation of high 
quality data from the African continent and dialog to facilitate mutual data sharing among 
international consortia of stroke genomics studies and investigators from the African 
continent, especially those currently involved in the SIREN study, through conferences and 
funded research collaborations.
4.6.4 Functional Genomics—Identified variants and target genomic loci can be 
investigated further with functional genomics to unravel the molecular mechanisms 
mediating their action (expression) using a combination of transcriptomics, epigenomics and 
metabolomics studies. Epigenomics, transcriptomics, and metabolomics can be selected as 
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priority compared to other Omics mainly due to their relative maturity and feasibility of 
implementing in large international consortium settings.
5.0 Conclusions
To revolutionize the understanding of genomic contributions to stroke occurrence, severity, 
type and outcome, the best potential is provided by expanding available high quality, 
comprehensive, accurate phenotype and genomic data in continental Africans for 
independent trans-omics analyses, and then combining this with big data from African 
Americans and other populations in trans-ethnic trans-Omics meta-analyses. Delineation of 
molecular mechanisms of validated genomic determinants of stroke can facilitate the 
development of a new array of precise biomarkers for stroke prediction, diagnosis and 
prognostic estimates as well as discovery of new therapeutic targets for personalized 
interventions 19. These developments could revolutionize stroke prevention, treatment and 
recovery globally.
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